Breast cancer, Ovarian cancer, Secondary cancers, Womb (uterine or endometrial) cancer
Open
Phase 2
This trial is comparing a new drug called opevesostat with standard treatment for some .
It is for people whose cancer has spread and have one of the following:
breast cancer
ovarian cancer
womb cancer
You pronounce opevesostat as oh-peh-ves-o-stat.
Recruitment start: 15 September 2025
Recruitment end: 18 December 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rowan Miller
Merck Sharp & Dohme Ltd
Last reviewed: 29 Jan 2026
CRUK internal database number: 20118
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
